Singapore markets closed
Straits Times Index
3,323.20 -6.89 (-0.21%) S&P 500
5,306.04 +1.32 (+0.02%) Dow
38,852.86 -216.74 (-0.55%) Nasdaq
17,019.88 +99.08 (+0.59%) Bitcoin USD
67,767.75 -572.02 (-0.84%) CMC Crypto 200
1,460.81 -23.88 (-1.61%)
PFE Mar 2025 15.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:46PM EDT. Market open.
| Previous close | 13.40 |
| Open | 13.30 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 15.00 |
| Expiry date | 2025-03-21 |
| Day's range | 13.30 - 13.40 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
ZacksPfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
ZacksPharma Stock Roundup: AZN's 2030 Sales Target, PFE's New Cost Cut Plan & More
AstraZeneca (AZN) announces an ambitious target of achieving $80 billion in revenues by 2030. Pfizer (PFE) announces a multi-year, multi-phase cost reduction program.
ZacksPfizer (PFE) Starts Another Cost-Cut Plan to Save $1.5B by 2027
This is the second cost-reduction program undertaken by Pfizer (PFE) in the past year. The first phase of this program is expected to save nearly $1.5 billion by 2027-end.
© 2024 Yahoo. All rights reserved.